136 related articles for article (PubMed ID: 35317506)
1. Serum Heat Shock Protein 70 Level in Children with Attention Deficiency Hyperactivity Disorder.
Özaslan A; Güney E; Gülbahar Ö; Büyüktaşkin Tunçtürk D; Arslan B; Güveli Bozkurt GM
Noro Psikiyatr Ars; 2022; 59(1):63-67. PubMed ID: 35317506
[TBL] [Abstract][Full Text] [Related]
2. Serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder.
Buyuktaskin D; Guney E; Gulbahar O; Ozaslan A; Arslan B
Int J Neurosci; 2024 Apr; 134(4):313-317. PubMed ID: 35815398
[No Abstract] [Full Text] [Related]
3. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Percinel I; Yazici KU; Ustundag B
Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
[TBL] [Abstract][Full Text] [Related]
4. Increased serum thioredoxin levels are not correlated with executive functions in children with attention deficit hyperactivity disorder.
Guney E; Buyuktaskin D; Tas Torun Y; Arslan B; Gulbahar O; Ozaslan A; Isik Taner Y; Iseri E
Neurosci Lett; 2019 Jul; 705():118-123. PubMed ID: 31028843
[TBL] [Abstract][Full Text] [Related]
5. Increased Serum Level of CCL5 in Children with Attention‑Deficit/Hyperactivity Disorder: First Results about Serum Chemokines.
Özaslan A; Güney E; Gülbahar Ö; Büyüktaskin D; Arslan B
Clin Psychopharmacol Neurosci; 2022 Feb; 20(1):109-117. PubMed ID: 35078953
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence.
Deb S; Dhaliwal AJ; Roy M
J Intellect Disabil Res; 2008 Nov; 52(11):950-65. PubMed ID: 18179511
[TBL] [Abstract][Full Text] [Related]
7. Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.
Bilgiç A; Toker A; Uysal S
Psychiatry Clin Neurosci; 2016 Oct; 70(10):442-447. PubMed ID: 27283127
[TBL] [Abstract][Full Text] [Related]
8. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD).
Darwish AH; Elgohary TM; Nosair NA
J Child Neurol; 2019 Feb; 34(2):61-67. PubMed ID: 30430896
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of Interleukin-6 and Tumor Necrosis Factor Alpha in Children With Attention-Deficit Hyperactivity Disorder.
Elsadek AE; Al-Shokary AH; Abdelghani WE; Kamal NM; Ibrahim AO; El-Shorbagy HH; Suliman HA; Barseem NF; Abdel Maksoud YH; Azab SM; Nour El Din DM
J Pediatr Neurosci; 2020; 15(4):402-408. PubMed ID: 33936305
[TBL] [Abstract][Full Text] [Related]
11. Evidence supporting the role of telomerase, MMP-9, and SIRT1 in attention-deficit/hyperactivity disorder (ADHD).
Uzun Cicek A; Mercan Isik C; Bakir S; Ulger D; Sari SA; Bakir D; Cam S
J Neural Transm (Vienna); 2020 Oct; 127(10):1409-1418. PubMed ID: 32691156
[TBL] [Abstract][Full Text] [Related]
12. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
McClain MB; Hasty Mills AM; Murphy LE
Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency in school-age Iranian children with attention-deficit/hyperactivity disorder (ADHD) symptoms: A critical comparison with healthy controls.
Fasihpour B; Moayeri H; Shariat M; Keihanidoust Z; Effatpanah M; Khedmat L
Child Neuropsychol; 2020 May; 26(4):460-474. PubMed ID: 31514566
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine, Pyridoxine, Folate and Vitamin B12 Levels in Children with Attention Deficit Hyperactivity Disorder.
Altun H; Şahin N; Belge Kurutaş E; Güngör O
Psychiatr Danub; 2018 Sep; 30(3):310-316. PubMed ID: 30267523
[TBL] [Abstract][Full Text] [Related]
15. Relationship between anxiety, anxiety sensitivity and conduct disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Bilgiç A; Türkoğlu S; Ozcan O; Tufan AE; Yılmaz S; Yüksel T
Eur Child Adolesc Psychiatry; 2013 Sep; 22(9):523-32. PubMed ID: 23460041
[TBL] [Abstract][Full Text] [Related]
16. Ubiquinone Levels as a Marker of Antioxidant System in Children with Attention Deficit Hyperactivity Disorder.
Karagöz YS; Doğan Ö; Elgün S; Öztop DB; Kılıç BG
J Mol Neurosci; 2021 Oct; 71(10):2173-2178. PubMed ID: 33245486
[TBL] [Abstract][Full Text] [Related]
17. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
Villemonteix T; Purper-Ouakil D; Romo L
Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
[TBL] [Abstract][Full Text] [Related]
18. Resting metabolic rate, pulmonary functions, and body composition parameters in children with attention deficit hyperactivity disorder.
Alpaslan AH; Ucok K; Coşkun KŞ; Genc A; Karabacak H; Guzel HI
Eat Weight Disord; 2017 Mar; 22(1):91-96. PubMed ID: 26573986
[TBL] [Abstract][Full Text] [Related]
19. Thiols and ceruloplasmin levels in serum of children with attention deficit hyperactivity disorder: A cross-sectional study.
Öğütlü H; Mertoğlu C; Gök G; Neşelioğlu S
Psychiatry Res; 2020 Dec; 294():113546. PubMed ID: 33160216
[TBL] [Abstract][Full Text] [Related]
20. High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain.
Kasahara S; Niwa SI; Matsudaira K; Sato N; Oka H; Fujii T; Konno SI; Kikuchi SI; Yamada Y
Pain Physician; 2021 May; 24(3):E299-E307. PubMed ID: 33988951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
